| Accession Number: | 0001209191-23-052466 |
| Date: | 2023-10-09 |
| Issuer: | ULTRAGENYX PHARMACEUTICAL INC. (RARE) |
| Original Submission Date: |
HORN HOWARD
C/O ULTRAGENYX PHARMACEUTICAL INC.
60 LEVERONI COURT
NOVATO, CA 94949
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2023-10-09 | A | 80,366 | a | $0.00 | 80,336 | direct |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| STOCK OPTION (RIGHT TO BUY) | 35.68 | 2023-10-09 | deemed execution date | A | 140,469 (a) | 2033-10-09 | common stock 140,469 | $35.68 | 140,469 | direct |
| ID | footnote |
|---|---|
| f1 | award of restricted stock units ("rsus") under the company's employment inducement plan. the rsus shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the rsus are fully vested on the fourth anniversary of the grant date. |
| f2 | the option shall vest with respect to 1/4th of the shares on the first anniversary of the grant date of the option and 1/48th of the shares initially subject to the option shall continue to vest on each month such that the option will fully vest on the fourth anniversary of the grant date. |
